Expansion

Quote


I've had a phone screen with Princeton One and then a phone screen with the hiring manager. First face-to-face is supposed to be mid-April for hire date in June for a start in July.
 
Well, this is your prototypical "Cart before the Horse" situation. This is the start of our Pharma downfall. Unless a company can substantially prove that a new entrant into an already crowded space, especially with lower cost drug alternatives, then the FDA has the power to just say no!!! The day of MeToo products are over.
 
anonymous said:
Well, this is your prototypical "Cart before the Horse" situation. This is the start of our Pharma downfall. Unless a company can substantially prove that a new entrant into an already crowded space, especially with lower cost drug alternatives, then the FDA has the power to just say no!!! The day of MeToo products are over.
Click to expand...


Your analysis of how the approval process works is childish.

It's efficacy is questionable, but not it's novelty. It's not a "me too" product.
 
at this point it doesn't really matter does it? It's not going to be approved in the foreseeable future w/o more data which takes time. Other products are under development for same disease state and may beat it to market. Slice, dice, spin, put lipstick on it or anything else you would like to do but this is simply not what ALKS had been hoping for. Aristada First!
 


Write your reply...
Top Bottom
Back
Quote